FATROXIMIN dry cow, 100 mg/5 ml intramammary ointment for cows and buffalo cows
FATROXIMIN dry cow, 100 mg/5 ml intramammary ointment for cows and buffalo cows
Authorised
- Rifaximin
Product identification
Medicine name:
FATROXIMIN dry cow, 100 mg/5 ml intramammary ointment for cows and buffalo cows
Active substance:
- Rifaximin
Target species:
-
Buffalo
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Rifaximin100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
-
Buffalo
-
Milk0hourΜηδέν ώρες (μηδέν αρμέγματα) μετά τον τοκετό, εάν η περίοδος ξηρασίας είναι ίση ή μεγαλύτερη από 49 ημέρες,
49 ημέρες μετά τη θεραπεία εάν η περίοδος ξηρασίας είναι μικρότερη από 49 ημέρες. -
Meat and offal0dayΝα μην χρησιμοποιούνται οι μαστοί των ζώων που υποβάλλονται σε θεραπεία για ανθρώπινη κατανάλωση.
-
-
Cattle
-
Meat and offal0day
-
Milk0hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51XX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- CY00078V
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 18/06/2024
